Licensed providers can adjust dosage or switch medications at no additional cost
The mean weight change from baseline to 12 months in terms of percentage of baseline weight was 5% (95% CI, 6% to 3%)
doi:10.1007/s00210-024-03378-z Pal S, Maurya SK, Chattopadhyay S, et al
The Phase 3 clinical trial program includes seven additional studies beyond TRIUMPH-4, all evaluating the injectable formulation
Baseline labs: CBC with differential, CMP, urinalysis with protein/creatinine ratio, C3 and C4 complement, anti-dsDNA, ESR, hsCRP, HbA1c, fasting glucose, lipid panel, TSH, liver enzymes